The Melanoma Research Alliance (MRA) is the largest private funder of melanoma research. Since its founding in 2007, MRA has committed $143 million in funding to advance our understanding of this disease. MRA funds projects in the areas of prevention, diagnosis, and treatment, with the majority of funding allocated for melanoma treatment. Due to the ongoing support of our founders, 100% of every donation to MRA supports melanoma research. The mission of the Melanoma Research Alliance is to accelerate the pace of scientific discovery and its translation into effective options for patients -- in prevention, diagnosis, prognosis, and treatment -- in order to eliminate suffering and death due to melanoma.
